Catch cancer sooner using the body's own signals
Nature-Inspired Detection, Engineered for Precision
TOBY mimics the disease-sensing power of dogs, using urine signatures and AI for fast, noninvasive cancer screening
The Science
From Molecular Signatures to Early Detection.
Dogs can detect illness by sensing volatile organic compounds (VOCs)—tiny molecules released by the body when disease is present. TOBY applies this principle through a technology called volatolomics, which translates scent-based biology into modern diagnostics.
We begin with spectroscopy, analyzing the molecular signature of VOCs in urine. These signatures reflect real-time changes in physiology and metabolism. Our proprietary AI interprets this complex data to identify early patterns of disease, often before symptoms appear.
Unlike traditional diagnostics that rely on imaging or genetic sequencing, TOBY focuses on what the body emits in the moment. This approach is fast, scalable, and noninvasive—offering a new pathway for early detection across multiple cancer types.
We do not just detect cancer. We interpret the body’s chemical signals and turn them into actionable insights.
The Technology
Built with Depth, Protected by Design.
Our algorithms are the result of deep research, development, and training on diverse biological signatures. Every model is engineered to learn from high-dimensional data, capturing subtle, disease-specific patterns with remarkable precision.
We keep our methods confidential to protect the integrity of our work and the competitive edge it provides. This commitment to privacy ensures our platform launches with performance, not noise.
By blending advanced spectroscopy, machine learning, and privacy-first architecture, TOBY delivers breakthrough diagnostics designed to scale without compromise.
